Brief Versus Standard Cognitive Behavioral Therapy for Insomnia in Veterans
Stopped early · Not applicable
Conditions studied: Insomnia
In brief
Insomnia is a common condition in Veterans, with prevalence rates as high as 53% among treatment-seeking Veterans. Chronic untreated insomnia is associated with increased risk for functional impairment, psychiatric illness, suicidal ideation, unhealthy lifestyles, and decreased quality of life. Cognitive-Behavioral Therapy for Insomnia (CBT-I) is recognized as the first-line treatment for insomnia. Despite its proven efficacy, CBT-I is not always readily provided and/or accessible to Veterans. To address these limitations, behavioral sleep medicine specialists have endeavored to streamline CBT-I through development of time-shortened variations of CBT-I. Although these modifications show promise for advancing care and access, studies comparing brief treatments to standard CBT-I have yet to be performed. This investigation will therefore compare a 4-session brief CBT-I to VA standard 6-session CBT-I to evaluate whether a brief intervention can provide comparable benefits to sleep, functional, and psychiatric outcomes in Veterans with insomnia.
Key facts
- Study ID
- NCT05724498
- Run by
- VA Office of Research and Development
- People needed
- 15
- Starts
- 2023-05-01
- Expected to finish
- 2025-10-01
- Last updated by the study team
- 2026-03-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- A diagnosis of insomnia as classified by the (a) Diagnostic and Statistical Manual of Mental Disorders-5 (DSM 5) which includes daytime impairment in functioning for > 3 months and occurring at least 3 nights per week and (b) subjective sleep disturbance defined by an Insomnia Severity Index (ISI) score >7 at intake
- Meets current DSM 5 criteria for a comorbid mental health disorder
- No formal therapist guided treatment with brief or standard Cognitive-Behavioral Therapy for Insomnia within the past 2 years
- on stable medication regimen for at least 4 weeks prior to enrollment in study.
You may not qualify if…
- History of a acute or unstable neurological disorder(s), dementia, or premorbid IQ <70
- Schizophrenia, psychotic disorder, and/or bipolar disorder
- Suicidality more than "medium risk" as determined by the VA Comprehensive Suicide Risk Assessment
- Sleep disturbances other than insomnia (e.g., untreated obstructive sleep apnea, periodic limb movements, narcolepsy, and/or circadian-based sleep disruptions)
- alcohol and/or substance use disorder for 90 days prior to intake, but past history of alcohol and/or substance use is not exclusionary.
Where it is running
- VA San Diego Healthcare System, San Diego, CA — San Diego, California, United States
- VA Finger Lakes Healthcare System, Canandaigua, NY — Canandaigua, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.